47 employees
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
2020
$85M
from 5 investors over 5 rounds
Ambagon Therapeutics raised $85M on January 6, 2022
Investors: Nextech Invest, RA Capital Management, L.P., Mission BioCapital, Inkef and Surveyor Capital